| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5657602 | Clinical Gastroenterology and Hepatology | 2017 | 41 Pages |
Abstract
In a randomized controlled trial of the ability of montelukast to maintain remission in patients in remission from EoE after steroid therapy, we found montelukast to be well tolerated; 40% of patients remained in remission, but this proportion did not differ significantly from that of the placebo group. ClinicalTrials.gov no: NCT00511316.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Jeffrey A. Alexander, Karthik Ravi, Felicity T. Enders, Debra M. Geno, Lori A. Kryzer, Kristin C. Mara, Thomas C. Smyrk, David A. Katzka,